Healthy Volunteers Clinical Trial
Official title:
Effects of Massage on the Short-term Post-exercise Recovery on Functional, Clinical and Metabolic Outcomes
Objectives: To analyze the behavior of the effects of massage on clinical, metabolic and
functional variables in different scenarios: i) under no stress or massage application; ii)
after massage; iii) after exhaustion protocol; iv) after the immediate application of
post-exercise massage; v) after application of the massage 1hour post-exercise.
Method: This was a randomized cross-over clinical trial in which 24 participants had their
clinical, functional and metabolic outcome data analyzed under different scenarios: i)
control scenario (CO): basal condition (under no stress or massage application); ii) Massage
(MA): after receiving the massage; iii) Exhaustion protocol (PE): after protocol of
exhaustion; iv) PE + immediate massage (EMI): after the protocol of exhaustion followed
immediately by massage; iv) PE + delayed massage (EMT): after the protocol of exhaustion and
massage received 1h after its end. The exhaustion protocol used consisted of 10 series of 10
jumps and one Wingate test and the manual massage protocol was composed of 12 minutes of
massage, 3 minutes for the anterior region of the thigh of each lower limb and 6 minutes to
the dorsal trunk. The variables studied were: muscle soreness, perceived recovery, maximal
voluntary isometric contraction (MVIC), strength and power in the guided bar, vertical jump
and blood lactate concentration [Lac].
Measurements. The primary outcome measures will be measured 2h after the start of each stage,
and the secondary outcome measures will be measured at specific times during each stage. The
primary outcome includes measures of functional performance, and the measures of secondary
outcome includes clinical and metabolic variables.
Introduction: Background: Massage has been shown over the years a recuperative technique
widely used in sports. Studies demonstrate divergent results of the technique in terms of
recovery of functional, clinical and metabolic performance after exercise. The wide
methodological variety of these studies, as in relation to the moment of massage application,
may be a possible justification for such a scenario. Thus, the study investigating the
effects of massage applied at different moments of post-exercise recovery deserves to be
highlighted.
Objectives: To analyze the behavior of the effects of massage on clinical, metabolic and
functional variables in different scenarios: i) under no stress or massage application; ii)
after massage; iii) after exhaustion protocol; iv) after the immediate application of
post-exercise massage; v) after application of the massage 1hour post-exercise.
Design: A cross-over randomized clinical trial.
Method: This was a randomized cross-over clinical trial in which 24 participants had their
clinical, functional and metabolic outcome data analyzed under different scenarios: i)
control scenario (CO): basal condition (under no stress or massage application); ii) Massage
(MA): after receiving the massage; iii) Exhaustion protocol (PE): after protocol of
exhaustion; iv) PE + immediate massage (EMI): after the protocol of exhaustion followed
immediately by massage; iv) PE + delayed massage (EMT): after the protocol of exhaustion and
massage received 1h after its end. Exhaustion protocol: consisted of 10 series of 10 jumps
and one Wingate test. Manual massage protocol: was composed of 12 minutes of massage, 3
minutes for the anterior region of the thigh of each lower limb and 6 minutes to the dorsal
trunk.
Measurements. The primary outcome measures will be measured 2h after the start of each stage,
and the secondary outcome measures will be measured at specific times during each stage. The
primary measures includes the Strength and power test, Maximal voluntary isometric
contraction (MVIC) and Squat jump. The secondary measures includes the subjective pain
assessment, perception of recovery, psychological questionnaire, belief questionnaire and de
analysis blood lactate concentration.
The variables studied were: muscle soreness, perceived recovery, maximal voluntary isometric
contraction (MVIC), strength and power in the guided bar, vertical jump and blood lactate
concentration [Lac].
Analysis: The normality of the data will be evaluated through the Shapiro-Wilk test. The
sphericity of the data was tested by the Mauchly's test. In case of breach of the sphericity
assumption, Greenhouse-Geisser corrections were used. Effect size was calculated using
partial eta-square (η²) and interpreted as small (≥0.01), moderate (≥0.06) or large (≥0.14).
When identified a large effect size, was used the Friedman's test with post-hoc Bonferroni
test, for soreness and perceived recovery, and Repeated Measures ANOVA with post-hoc Tukey's
test for vertical jump and MVIC. The level of significance was set at 5%.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |